The CELsignia Platform
Using a patient’s live tumor cells
- CELsignia isolates the tumor cells from tumor tissue obtained from a biopsy.
- The tumor cells are then maintained as if they were in vivo, or inside the patient.
Analyzing pathway signaling activity
- Key pathways known to drive cancer are then analyzed and their signaling activity is quantified.
- Abnormal pathway signaling, undetected by molecular tests, is diagnosed
- Targeted therapies that treat abnormal pathway signaling are then identified.